These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 38835765)

  • 1. A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation.
    League AF; Yadav-Samudrala BJ; Kolagani R; Cline CA; Jacobs IR; Manke J; Niphakis MJ; Cravatt BF; Lichtman AH; Ignatowska-Jankowska BM; Fitting S
    Front Immunol; 2024; 15():1374301. PubMed ID: 38835765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal Hyperexcitability, Restores Dendritic Arborization Complexity, and Regulates Reward-Related Behavior in Presence of HIV-1 Tat.
    League AF; Gorman BL; Hermes DJ; Johnson CT; Jacobs IR; Yadav-Samudrala BJ; Poklis JL; Niphakis MJ; Cravatt BF; Lichtman AH; Ignatowska-Jankowska BM; Fitting S
    Front Neurol; 2021; 12():651272. PubMed ID: 34484091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory Control Deficits Associated with Upregulation of CB
    Jacobs IR; Xu C; Hermes DJ; League AF; Xu C; Nath B; Jiang W; Niphakis MJ; Cravatt BF; Mackie K; Mukhopadhyay S; Lichtman AH; Ignatowska-Jankowska BM; Fitting S
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):661-678. PubMed ID: 31372820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Novel Monoacylglycerol Lipase Inhibitor MJN110 Suppresses Neuroinflammation, Normalizes Synaptic Composition and Improves Behavioral Performance in the Repetitive Traumatic Brain Injury Mouse Model.
    Selvaraj P; Tanaka M; Wen J; Zhang Y
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegeneration.
    Hermes DJ; Yadav-Samudrala BJ; Xu C; Paniccia JE; Meeker RB; Armstrong ML; Reisdorph N; Cravatt BF; Mackie K; Lichtman AH; Ignatowska-Jankowska BM; Lysle DT; Fitting S
    Exp Neurol; 2021 Jul; 341():113699. PubMed ID: 33736974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids.
    Hermes DJ; Jacobs IR; Key MC; League AF; Yadav-Samudrala BJ; Xu C; McLane VD; Nass SR; Jiang W; Meeker RB; Ignatowska-Jankowska BM; Lichtman AH; Li Z; Wu Z; Yuan H; Knapp PE; Hauser KF; Fitting S
    J Neuroinflammation; 2020 Nov; 17(1):345. PubMed ID: 33208151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis.
    Guadalupi L; Mandolesi G; Vanni V; Balletta S; Caioli S; Pavlovic A; De Vito F; Fresegna D; Sanna K; Vitiello L; Nencini M; Tartacca A; Mariani F; Rovella V; Schippling S; Ruf I; Collin L; Centonze D; Musella A
    Neuropharmacology; 2024 Jul; 252():109940. PubMed ID: 38570068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of lower urinary tract dysfunction by a monoacylglycerol lipase inhibitor in mice with spinal cord injury.
    Cho KJ; Hashimoto M; Karnup S; Matsuoka K; Kamijo T; Kim JC; Koh JS; Yoshimura N
    Neurourol Urodyn; 2024 Jun; 43(5):1207-1216. PubMed ID: 38533637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice.
    Paris JJ; Singh HD; Carey AN; McLaughlin JP
    Behav Brain Res; 2015 Sep; 291():209-218. PubMed ID: 26005128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
    Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
    Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam Prevents Neurophysiological Changes and Preserves Cognitive Function in the Human Immunodeficiency Virus (HIV)-1 Transactivator of Transcription Transgenic Mouse Model of HIV-Associated Neurocognitive Disorder.
    Ewens AN; Pilski A; Hastings SD; Krook-Magnuson C; Graves SM; Krook-Magnuson E; Thayer SA
    J Pharmacol Exp Ther; 2024 Sep; 391(1):104-118. PubMed ID: 39060163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Repeated Treatment with the Monoacylglycerol Lipase Inhibitor MJN110 on Pain-Related Depression of Nesting and Cannabinoid 1 Receptor Function in Male and Female Mice.
    Diester CM; Balint H; Gillespie JC; Lichtman AH; Sim-Selley LJ; Selley DE; Negus SS
    J Pharmacol Exp Ther; 2024 Aug; 390(3):291-301. PubMed ID: 38262742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the effects of the HIV-1 protein Tat and morphine on antiretroviral accumulation and distribution within the brain.
    Jones AM; Rademeyer KM; Rosen EP; Contaifer S; Wijesinghe D; Hauser KF; McRae M
    Clin Transl Sci; 2024 Oct; 17(10):e70035. PubMed ID: 39382215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice.
    Rademeyer KM; R Nass S; Jones AM; Ohene-Nyako M; Hauser KF; McRae M
    J Neurovirol; 2024 Feb; 30(1):1-21. PubMed ID: 38280928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice.
    Ignatowska-Jankowska B; Wilkerson JL; Mustafa M; Abdullah R; Niphakis M; Wiley JL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2015 May; 353(2):424-32. PubMed ID: 25762694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation.
    Chivero ET; Guo ML; Periyasamy P; Liao K; Callen SE; Buch S
    J Neurosci; 2017 Mar; 37(13):3599-3609. PubMed ID: 28270571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
    Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Human Immunodeficiency Virus Transactivator of Transcription (HIV-Tat
    Cirino TJ; Alleyne AR; Duarte V; Figueroa A; Simons CA; Anceaume EM; Kendrick J; Wallman O; Eans SO; Stacy HM; Medina JM; McLaughlin JP
    J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):152-164. PubMed ID: 33619645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders.
    Puccini JM; Marker DF; Fitzgerald T; Barbieri J; Kim CS; Miller-Rhodes P; Lu SM; Dewhurst S; Gelbard HA
    J Neurosci; 2015 Apr; 35(13):5271-83. PubMed ID: 25834052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells.
    Lu SM; Tremblay MÈ; King IL; Qi J; Reynolds HM; Marker DF; Varrone JJ; Majewska AK; Dewhurst S; Gelbard HA
    PLoS One; 2011; 6(9):e23915. PubMed ID: 21912650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.